ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fight Back! Win the War Being Waged Against Your Immune System

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimm...

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Acupressure reduced fatigue in breast cancer survivors

Omega-3 fatty acid stops known trigger of lupus

What’s Fenugreek Good For?

Print Page
Email Article

Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies – Source: Retrovirology, Aug 17, 2010

  [ 8 votes ]   [ Discuss This Article ]
By Xiaoxing Qiu, et al. • • August 17, 2010

[Note: to read the full text of this article free, click HERE.]

Background: Xenotropic Murine Leukemia Virus-related Virus (XMRV) is a human gammaretrovirus recently identified in prostate cancer tissue and in lymphocytes of patients with chronic fatigue syndrome.

To establish the etiologic role of XMRV infection in human disease requires large scale epidemiologic studies. Development of assays to detect XMRV-specific antibodies would greatly facilitate such studies.

However, the nature and kinetics of the antibody response to XMRV infection have yet to be determined.

Results: Three rhesus macaques were infected with XMRV to determine the dynamics of the antibody responses elicited by infection with XMRV.

All macaques developed antibodies to XMRV during the second week of infection, and the predominant responses were to the envelope protein gp70, transmembrane protein p15E and capsid protein p30.

In general, antibody responses to gp70 and p15E appeared early with higher titers than to p30, especially in the early period of seroconversion.

Antibodies to gp70, p15E and p30 persisted to 158 days and were substantially boosted by re-infection, thus, were identified as useful serologic markers.

Three high-throughput prototype assays were developed using recombinant proteins to detect antibodies to these viral proteins. Both gp70 and p15E prototype assays demonstrated 100% sensitivity by detecting all Western Blot (WB) positive serial bleeds from the XMRV-infected macaques and good specificity (99.5-99.9%) with blood donors.

Seroconversion sensitivity and specificity of the p30 prototype assay was 92% and 99.4% respectively.

Conclusions: This study provides the first demonstration of seroconversion patterns elicited by XMRV infection.

• The nature and kinetics of antibody responses to XMRV in primates were fully characterized.

• Moreover, key serologic markers useful for detection of XMRV infection were identified.

• Three prototype immunoassays were developed to detect XMRV-specific antibodies.

• These assays demonstrated good sensitivity and specificity; thus will facilitate large scale epidemiologic studies of XMRV infection in humans.

Source: Retrovirology, Aug 17, 2010. doi:10.1186/1742-4690-7-68 by Qiu X, Swanson P, Luk K, Tu B, Villinger F, Das Gupta J, Silverman RH, Klein EA, Devare s, Schochetman g, Hackett J Jr. Abbott Diagnostics, Abbott Park, Illinois; Department of Pathology, Emory University School of Medicine/Yerkes National Primate Research Center, Atlanta, Georgia; Department of Cancer Biology, Lerner Research Institute, and Glick Urological and Kidney Institute and LRI, Cleveland Clinic Foundation, Cleveland, Ohio, USA. [See also “Characterization of XMRV in prostate cancer,” March 2010.]

Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Herbal Inflammation Management for Whole Body Health Herbal Inflammation Management for Whole Body Health
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10 Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10
Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map